Results 311 to 320 of about 452,381 (401)
Abstract Basal insulin and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are available in two fixed‐ratio combinations (FRCs) for the treatment of type 2 diabetes (T2D), insulin degludec with liraglutide and insulin glargine with lixisenatide.
Kevin Cowart, Nicholas W. Carris
wiley +1 more source
Abstract Aims This indirect treatment comparison (ITC) compared the efficacy and safety of tirzepatide with semaglutide for managing obesity or overweight in participants with type 2 diabetes (T2D), informed by the pivotal trials SURMOUNT‐2 and STEP 2.
Andreea Ciudin+9 more
wiley +1 more source
The Influence of Anti-PAR 1 and Anti-ACE 2 Antibody Levels on the Course of Specific Glomerulonephritis Types. [PDF]
Szymczak M+9 more
europepmc +1 more source
Glomerular function in advanced human diabetic nephropathy
Jan A. Winetz+4 more
openalex +1 more source
Abstract Aims This study evaluated clinical outcomes of oral semaglutide treatment in adults with type 2 diabetes (T2D) in a real‐world setting in Spain as part of the 13‐country PIONEER REAL programme. Materials and Methods This multicentre, prospective, non‐interventional, single‐arm study (NCT05443334) followed participants for 34–44 weeks ...
Elías Delgado Álvarez+10 more
wiley +1 more source
Tissue-specific mitochondrial DNA, <i>MT-TF,</i> pathogenic variants in mitochondrial myopathies. [PDF]
Rose S+9 more
europepmc +1 more source
MEMBRANOUS NEPHROPATHY IN CYCLOSPORINE-TREATED RENAL TRANSPLANT RECIPIENTS
G. Montagnino+5 more
openalex +1 more source